Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07416214
NA

Lactiplantibacillus Plantarum PD01 Supplementation Reduces Microplastics and Microplastic-associated Chemicals in Humans

Sponsor: Fudan University

View on ClinicalTrials.gov

Summary

The study attempts to conduct randomized double-blind controlled trials to understand whether daily exposure to microplastics (MPs) can cause potential impacts on human health, explore whether the intake of Lactiplantibacillus plantarum PD01 can alleviate potential obesity-related damages caused by MPs, and provide a scientific basis for the prevention and nutritional intervention of health hazards caused by MP exposure.

Official title: Lactiplantibacillus Plantarum PD01 Supplementation Reduces Microplastics and Microplastic-associated Chemicals in Humans: A Randomized, Double-blind, Placebo-controlled Trial

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

96

Start Date

2025-11-30

Completion Date

2026-02-10

Last Updated

2026-08-17

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

Probiotics (Lactiplantibacillus plantarum PD01)

The probiotic supplement includes 0.2g Lactiplantibacillus plantarum FABYIO PD01 (containing 10 billion CFU) and 1.8g Fructooligosaccharides.

DIETARY_SUPPLEMENT

Placebo

The placebo includes 2.0g Fructooligosaccharides with an indistinguishable appearance and texture.

Locations (1)

School of Public Health, Fudan University

Shanghai, Xuhui, China